EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension

Moritz I Wimmer iD, Hendrik Bartolomaeus iD, Harithaa Anandakumar iD, Chia-Yu Chen iD, Valentin Vecera iD, Sarah Kedziora iD, Sakshi Kamboj iD, Fabian Schumacher iD, Sidney Pals, Ariana Rauch iD, Jutta Meisel, Olena Potapenko iD und 14 weitere

Acta Physiologica · 2024-11 · 240 (11)

DOI: 10.1111/apha.14226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Physiologica, online erschienen am 10.09.2024. Verfasst von Moritz I Wimmer und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Medical Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität z…. Hauptthemen laut MEDLINE: Metformin, Hypertension, Gastrointestinal Microbiome, Blood Pressure. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Deutsches Zentrum für Herz-Kreislaufforschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Metformin has been attributed to cardiovascular protection even in the absence of diabetes. Recent observations suggest that metformin influences the gut microbiome. We aimed to investigate the influence of metformin on the gut microbiota and hypertensive target organ damage in hypertensive rats.

Methods

Male double transgenic rats overexpressing the human renin and angiotensinogen genes (dTGR), a model of angiotensin II‐dependent hypertension, were treated with metformin (300 mg/kg/day) or vehicle from 4 to 7 weeks of age. We assessed gut microbiome composition and function using shotgun metagenomic sequencing and measured blood pressure via radiotelemetry. Cardiac and renal organ damage and inflammation were evaluated by echocardiography, histology, and flow cytometry.

Results

Metformin treatment increased the production of short‐chain fatty acids (SCFA) acetate and propionate in feces without altering microbial composition and diversity. It significantly reduced systolic and diastolic blood pressure and improved cardiac function, as measured by end‐diastolic volume, E/A, and stroke volume despite increased cardiac hypertrophy. Metformin reduced cardiac inflammation by lowering macrophage infiltration and shifting macrophage subpopulations towards a less inflammatory phenotype. The observed improvements in blood pressure, cardiac function, and inflammation correlated with fecal SCFA levels in dTGR. In vitro, acetate and propionate altered M1‐like gene expression in macrophages, reinforcing anti‐inflammatory effects. Metformin did not affect hypertensive renal damage or microvascular structure.

Conclusion

Metformin modulated the gut microbiome, increased SCFA production, and ameliorated blood pressure and cardiac remodeling in dTGR. Our findings confirm the protective effects of metformin in the absence of diabetes, highlighting SCFA as a potential mediators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminHypertensionGastrointestinal MicrobiomeBlood PressureVentricular RemodelingRats, TransgenicAnimalsMaleRatsDisease Models, AnimalHypoglycemic AgentsFatty Acids, Volatile

Stichwörter der Autor:innen

cardiac remodelinghypertensioninflammationmetforminmicrobiomeshort‐chain fatty acids

Substanzen

MetforminHypoglycemic AgentsFatty Acids, Volatile

Autor:innen und Institutionen

  • Department of Nephrology and Medical Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Experimental and Clinical Research Center (ECRC), Charité-Universitätsmedizin Berlin, Max Delbruck Center for Molecular Medicine, Berlin, Germany.
  • Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • DZHK (German Centre for Cardiovascular Research), Berlin, Germany.
  • Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Institute of Functional Genomics, University of Regensburg, Regensburg, Germany.

ORCID-Profile: Moritz I Wimmer, Hendrik Bartolomaeus, Harithaa Anandakumar, Chia-Yu Chen, Valentin Vecera, Sarah Kedziora, Sakshi Kamboj, Fabian Schumacher, Ariana Rauch, Olena Potapenko, Alex Yarritu, Theda U P Bartolomaeus, Mariam Samaan, Arne Thiele, Sabrina Y Geisberger, Burkhard Kleuser, Peter J Oefner, Nadine Haase, Ulrike Löber, Wolfram Gronwald, Sofia K Forslund-Startceva, Dominik N Müller, Nicola Wilck

Förderung

  • Deutsche Forschungsgemeinschaft
  • Deutsches Zentrum für Herz-Kreislaufforschung

Zitieren

APA

Wimmer, M. I., Bartolomaeus, H., Anandakumar, H., Chen, C. Y., Vecera, V., Kedziora, S., Kamboj, S., Schumacher, F., Pals, S., Rauch, A., Meisel, J., Potapenko, O., Yarritu, A., Bartolomaeus, T. U. P., Samaan, M., Thiele, A., Stürzbecher, L., Geisberger, S. Y., Kleuser, B., …, & Wilck, N. (2024). Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension. Acta Physiologica, 240(11). https://doi.org/10.1111/apha.14226

Vancouver

Wimmer MI, Bartolomaeus H, Anandakumar H, Chen CY, Vecera V, Kedziora S, et al. Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension. Acta Physiologica. 2024;240(11). doi:10.1111/apha.14226

BibTeX
@article{Wimmer2024,
  author = {Wimmer, Moritz I and Bartolomaeus, Hendrik and Anandakumar, Harithaa and Chen, Chia-Yu and Vecera, Valentin and Kedziora, Sarah and Kamboj, Sakshi and Schumacher, Fabian and Pals, Sidney and Rauch, Ariana and Meisel, Jutta and Potapenko, Olena and Yarritu, Alex and Bartolomaeus, Theda U P and Samaan, Mariam and Thiele, Arne and Stürzbecher, Lucas and Geisberger, Sabrina Y and Kleuser, Burkhard and Oefner, Peter J and Haase, Nadine and Löber, Ulrike and Gronwald, Wolfram and Forslund-Startceva, Sofia K and Müller, Dominik N and Wilck, Nicola},
  title = {Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension},
  journal = {Acta Physiologica},
  year = {2024},
  volume = {240},
  number = {11},
  doi = {10.1111/apha.14226}
}
Kostenlos starten →